Ownership history in MACQUARIE GROUP LTD · 14 quarters on record
This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in DAY ONE BIOPHARMACEUTICALS I (DAWN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 110,000 | — | 0% | 0.00% | $776K | $7.05 |
| 2025 Q2 | UNCHANGED | 110,000 | — | 0% | 0.00% | $715K | $6.50 |
| 2025 Q1 | UNCHANGED | 110,000 | — | 0% | 0.00% | $872K | $7.93 |
| 2024 Q4 | UNCHANGED | 110,000 | — | 0% | 0.00% | $1.4M | $12.67 |
| 2024 Q3 | REDUCED | 110,000 | -603 | -0.5% | 0.00% | $1.5M | $13.93 |
| 2024 Q2 | ADDED | 110,603 | +603 | +0.5% | 0.00% | $1.5M | $13.78 |
| 2024 Q1 | UNCHANGED | 110,000 | — | 0% | 0.00% | $1.8M | $16.52 |
| 2023 Q4 | UNCHANGED | 110,000 | — | 0% | 0.00% | $1.6M | $14.60 |
| 2023 Q3 | UNCHANGED | 110,000 | — | 0% | 0.00% | $1.4M | $12.27 |
| 2023 Q2 | UNCHANGED | 110,000 | — | 0% | 0.00% | $1.3M | $11.94 |
As of 2025 Q4 — sorted by position size